| dc.contributor.author | Tahamtan, Mahshid | en_US |
| dc.contributor.author | Shamsizadeh, Ali | en_US |
| dc.contributor.author | Allahtavakoli, Mohammad | en_US |
| dc.contributor.author | Nami, Mohammad | en_US |
| dc.contributor.author | Mohammadi, Neda | en_US |
| dc.contributor.author | Hassanshahi, Gholamhossein | en_US |
| dc.date.accessioned | 1399-07-08T21:55:33Z | fa_IR |
| dc.date.accessioned | 2020-09-29T21:55:33Z | |
| dc.date.available | 1399-07-08T21:55:33Z | fa_IR |
| dc.date.available | 2020-09-29T21:55:33Z | |
| dc.date.issued | 2017-12-01 | en_US |
| dc.date.issued | 1396-09-10 | fa_IR |
| dc.date.submitted | 2018-07-22 | en_US |
| dc.date.submitted | 1397-04-31 | fa_IR |
| dc.identifier.citation | Tahamtan, Mahshid, Shamsizadeh, Ali, Allahtavakoli, Mohammad, Nami, Mohammad, Mohammadi, Neda, Hassanshahi, Gholamhossein. (2017). Differential Expression of CXCL1, CXCL10, and CXCL12 in Response to Cerebral Ischemic Postconditioning in Rat Brain. Journal of Advanced Medical Sciences and Applied Technologies, 3(4), 197-204. doi: 10.32598/jamsat.3.4.197 | en_US |
| dc.identifier.issn | 2423-5903 | |
| dc.identifier.issn | 2538-4473 | |
| dc.identifier.uri | https://dx.doi.org/10.32598/jamsat.3.4.197 | |
| dc.identifier.uri | https://jamsat.sums.ac.ir/article_42511.html | |
| dc.identifier.uri | https://iranjournals.nlai.ir/handle/123456789/121113 | |
| dc.description.abstract | Objectives: Cerebral ischemic preconditioning lessens stroke-induced injuries, but it is clinically feasible only when the occurrence of stroke is predictable. Reperfusion plays a critical role against cerebral injury after stroke; we tested the hypothesis that interrupting ischemia during early reperfusion, i.e. Postconditioning (POCO) affects CXC chemokine expression and further reduce inflammation in rat model of ischemia/reperfusion. Materials & Methods: Adult male Wistar rats (250-300 g) were used in this experiment. Using 4-vessel occlusion method, global cerebral ischemia was induced and POCO was performed by applying 3 cycles of 15-s/15-s reperfusion/reocclusion after a 45-s reperfusion (POCO-45-15/15). Western blotting analysis was used to investigate CXCL1, CXCL10 and CXCL12 expression 24 h, 48 h and one week after ischemic postconditioning (iPOCO).Results: Based on the results, iPOCO attenuates the expression of inflammatory chemokines CXCL1 and CXCL10 in hippocampus area of postconditioned rats, while the CXCL12 was not affected by iPOCO.Conclusion: Current findings may support chemokines role in iPOCO via reduction of inflammation. Also there could be a link between postconditioning, stress and inflammation through chemokines. | en_US |
| dc.language | English | |
| dc.language.iso | en_US | |
| dc.publisher | Shiraz University of Medical Sciences | en_US |
| dc.relation.ispartof | Journal of Advanced Medical Sciences and Applied Technologies | en_US |
| dc.relation.isversionof | https://dx.doi.org/10.32598/jamsat.3.4.197 | |
| dc.subject | Chemokine | en_US |
| dc.subject | Global cerebral ischemia | en_US |
| dc.subject | Postconditioning | en_US |
| dc.title | Differential Expression of CXCL1, CXCL10, and CXCL12 in Response to Cerebral Ischemic Postconditioning in Rat Brain | en_US |
| dc.type | Text | en_US |
| dc.type | Original Articles | en_US |
| dc.contributor.department | Physiology Pharmacology Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. | en_US |
| dc.contributor.department | Physiology Pharmacology Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. | en_US |
| dc.contributor.department | Physiology Pharmacology Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. | en_US |
| dc.contributor.department | Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran. | en_US |
| dc.contributor.department | Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran. | en_US |
| dc.contributor.department | Molecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. | en_US |
| dc.citation.volume | 3 | |
| dc.citation.issue | 4 | |
| dc.citation.spage | 197 | |
| dc.citation.epage | 204 | |
| nlai.contributor.orcid | 0000-0002-6299-6902 | |
| nlai.contributor.orcid | 0000-0003-1410-5340 | |
| nlai.contributor.orcid | 0000-0002-4829-1586 | |